HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Analysis of the Type 1 Diabetes Genetics Consortium Families
Article Information
vol. 57 no. 4 1084-1092
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 18, 2007
- Accepted January 14, 2008
- Published in print March 27, 2008.
- Published online ahead of print February 5, 2008.
Article Versions
- Previous version (February 5, 2008 - 12:47).
- You are viewing the most recent version of this article.
Copyright & Usage
DIABETES
Author Information
- Henry Erlich1,2,
- Ana Maria Valdes2,
- Janelle Noble2,
- Joyce A. Carlson3,
- Mike Varney4,
- Pat Concannon5,
- Josyf C. Mychaleckyj5,
- John A. Todd6,
- Persia Bonella2,
- Anna Lisa Fear2,
- Eva Lavant3,
- Anthony Louey4,
- Priscilla Moonsamy1 and
- for the Type 1 Diabetes Genetics Consortium
- 1Roche Molecular Systems, Alameda, California
- 2Children's Hospital Oakland Research Institute, Oakland, California
- 3Clinical Chemistry, University Hospital, Malmö, Sweden
- 4Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Melbourne, Australia
- 5Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia
- 6Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, U.K
- Address correspondence and reprint requests to Henry A. Erlich, PhD, Roche Molecular Systems, 1145 Atlantic Ave., Alameda, CA 94501. E-mail: Henry.Erlich{at}Roche.com